Communication between gastrointestinal bacteria and the nervous system
In the past few years, intestinal microbiota has emerged as a novel target for the treatment of
gut–brain axis alterations. These include functional gastrointestinal disorders, such as
irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric
conditions. Thus, modulation of the microbiota (eg with the use of probiotics) could be
proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for
psychiatric treatment of anxiety and depression.
gut–brain axis alterations. These include functional gastrointestinal disorders, such as
irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric
conditions. Thus, modulation of the microbiota (eg with the use of probiotics) could be
proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for
psychiatric treatment of anxiety and depression.